Centronuclear Myopathy (CNM) is a rare genetic muscle disorder that affects both males and females of all ages. It is characterized by muscle weakness and abnormal positioning of the nuclei within muscle cells, hence the name "centronuclear."
Symptoms: Individuals with CNM may experience muscle weakness, particularly in the facial, neck, and limb muscles. This can lead to difficulties with swallowing, breathing, and mobility. Some individuals may also have delayed motor milestones, such as delayed walking.
Causes: CNM is caused by mutations in certain genes that are involved in muscle cell function. These mutations disrupt the normal processes within muscle cells, leading to the characteristic features of the condition.
Diagnosis: Diagnosis of CNM involves a combination of clinical evaluation, muscle biopsies, and genetic testing. Muscle biopsies can reveal the abnormal positioning of nuclei within muscle cells.
Treatment: Currently, there is no cure for CNM, but management focuses on addressing symptoms and improving quality of life. This may involve physical therapy, assistive devices, respiratory support, and other supportive measures.
Prognosis: The prognosis for individuals with CNM varies depending on the severity of symptoms. While some individuals may have mild symptoms and a normal lifespan, others may experience significant disability and respiratory complications.